Aastrom Biosciences News (NASDAQ:ASTM)
| Latest Aastrom Biosciences News Headlines | | Date | Time | Source | | | 05/22/2007 | 11:57AM | PRNUS | BullMarket.com Updates Outlooks on Stem Cell Companies
PRINCETON, N.J., May 22 /PRNewswire/ -- BullMarket.com (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced today that it has provided subscribers with a detailed report updating outlooks on stem cell companies including Geron (NASDAQ:GERN... More...>> |
| 03/09/2007 | 12:00PM | PRNUS | Aastrom to Present at Cowen & Company 27th Annual Health Care Conference
ANN ARBOR, Mich., March 9 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a company developing cell-based therapeutics for regenerative medicine, today announced that Gerald D. Brennan, Jr., Vice President, Administrative & Financial Operations and Chief Financial Officer will present at the Cowen... More...>> |
| 02/14/2007 | 10:00AM | PRNUS | Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
-- Additional Positive Patient Treatment Results Presented at the American Academy of Orthopaedic Surgeons Meeting --
ANN ARBOR, Mich., Feb. 14 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a company developing cell-based therapeutics for regenerative medicine, today announced that 90% of the patients... More...>> |
| 02/07/2007 | 7:00AM | PRNUS | Aastrom Reports Second Quarter Fiscal Year 2007 Financial Results
ANN ARBOR, Mich., Feb. 7 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a company developing cell-based therapeutics for regenerative medicine, today reported financial results for the second fiscal quarter ended December 31, 2006. The Company also reported operational achievements during the quarter... More...>> |
| 02/01/2007 | 7:00AM | PRNUS | Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
- Up to 150,000 People in U.S. Currently Suffer from this Severe Chronic Heart Disease
ANN ARBOR, Mich., Feb. 1 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a company focused on the use of autologous cells for regenerative medicine, today announced that the Company's proprietary Tissue Repair Cells... More...>> |
| 01/17/2007 | 1:07PM | PRNUS | Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
- Pivotal Bone Regeneration Trial Underway in Spain -
ANN ARBOR, Mich., Jan. 17 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a company focused on the use of autologous cells for regenerative medicine, today announced that the first two patients have been treated in a pivotal clinical trial utilizing... More...>> |
| 12/14/2006 | 3:30PM | PRNUS | Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
-- Appointment Supports New Initiatives --
ANN ARBOR, Mich., Dec. 14 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, today announced that Sheldon A. Schaffer, Ph.D. has joined the Company as Vice... More...>> |
| 12/07/2006 | 4:00PM | PRNUS | Aastrom Biosciences to Present at RBC Capital Markets Healthcare Conference
ANN ARBOR, Mich., Dec. 7 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, today announced that George W. Dunbar, President and Chief Executive Officer will participate on the Tissue, Blood & Bone:... More...>> |
| 11/30/2006 | 2:30PM | PRNUS | Aastrom Biosciences To Present at BMO Capital Markets Healthcare Conference
ANN ARBOR, Mich., Nov. 30 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, today announced that George W. Dunbar, President and Chief Executive Officer, and Elmar R. Burchardt, M.D., Ph.D., will present... More...>> |
| 11/16/2006 | 8:00AM | PRNUS | Stephen G. Sudovar Elected Chairman of Aastrom Biosciences' Board of Directors
ANN ARBOR, Mich., Nov. 16 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, announced today that Stephen G. Sudovar, CEO of SGS Associates and former President of Roche Laboratories, Inc., has been... More...>> |
| 11/09/2006 | 7:00AM | PRNUS | Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2007 Financial Results
- Company Reports Clinical Progress and Strengthened Management Team -
ANN ARBOR, Mich., Nov. 9 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM), a late-stage development company focused on the use of autologous cells for regenerative medicine, today reported financial results for the first fiscal quarter... More...>> |
| 11/02/2006 | 4:00PM | PRNUS | Aastrom Biosciences to Present at Rodman & Renshaw 8th Annual Healthcare Conference
ANN ARBOR, Mich., Nov. 2 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, and Elmar R. Burchardt, MD, PhD, Vice President, Medical Affairs, will present at the Rodman & Renshaw 8th Annual Healthcare Conference. The conference... More...>> |
| 10/16/2006 | 7:00AM | PRNUS | Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences as Vice President Research & Development
- Appointment Brings Strong Product Development Leadership to Company -
ANN ARBOR, Mich., Oct. 16 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that Ronnda L. Bartel, Ph.D. has joined the Company as Vice President of Research and Development. Dr. Bartel is responsible for the product... More...>> |
| 10/12/2006 | 4:00PM | PRNUS | Aastrom Biosciences to Present at BIO Investor Forum
ANN ARBOR, Mich., Oct. 12 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, will be presenting at the 2006 BIO Investor Forum. The Investor Forum will be held October 18-19th at the Palace Hotel in San Francisco, California... More...>> |
| 09/21/2006 | 4:00PM | PRNUS | Aastrom Biosciences' CFO to Present at Noble Financial Group Small Cap Conference
ANN ARBOR, Mich., Sept. 21 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that Gerald D. Brennan, Jr., Vice President Administrative & Financial Operations and Chief Financial Officer, will present at the Noble Financial Group Small Cap Conference. The conference will be held September... More...>> |
| 09/15/2006 | 1:00PM | PRNUS | Aastrom Biosciences Reports Interim Data from Long Bone Non-Union Fracture Clinical Trial
Promising Results Demonstrated in Patients
ANN ARBOR, Mich., Sept. 15 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today reported additional interim results from patients enrolled in its U.S. Phase I/II multi-center clinical trial evaluating Tissue Repair Cells (TRCs) in the treatment of recalcitrant... More...>> |
| 09/14/2006 | 4:31PM | PRNUS | Aastrom Biosciences to Present at Merriman Curhan Ford & Co. 3rd Annual Investor Summit
ANN ARBOR, Mich., Sept. 14 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, Gerald D. Brennan, Jr., Vice President Administrative & Financial Operations and Chief Financial Officer, and Elmar R. Burchardt, M.D., Ph.D., Vice... More...>> |
| 09/13/2006 | 7:00AM | PRNUS | Aastrom Biosciences, Inc. Reports Fourth Quarter and Fiscal Year 2006 Financial Results
ANN ARBOR, Mich., Sept. 13 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2006. The Company also reported several clinical and operational achievements during the quarter, including:
* Completion of the accrual... More...>> |
| 07/27/2006 | 7:15AM | PRNUS | Aastrom Biosciences Appoints Senior Director Medical Affairs
Expert Cardiologist to Lead Clinical Programs
ANN ARBOR, Mich., July 27 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) announced today the appointment of Elmar R. Burchardt, M.D., Ph.D., to the new position of Senior Director Medical Affairs. Dr. Burchardt is responsible for directing all of Aastrom's... More...>> |
| 07/17/2006 | 6:00AM | PRNUS | George W. Dunbar Joins Aastrom Biosciences as Chief Executive Officer
- Appointment Adds Strong Industry Leader to Adult Stem Cell Company -
ANN ARBOR, Mich., July 17 /PRNewswire-FirstCall/ -- Aastrom Biosciences, Inc. (NASDAQ:ASTM) today announced that George W. Dunbar, Jr. has joined the Company as Chief Executive Officer, President, and a member of Aastrom's Board of Directors. R... More...>> |
|
|
|